Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
Clinical trial NCT07560358 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07560358
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2029-12-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.